GlassScriptPhysician profile
Brian J Foster
NPI 1881646651
$4,980.92
in general payments reported to CMS, 2019-2025
45 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $228 · 2021: $1,139 · 2022: $1,252 · 2023: $926 · 2024: $379 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,644.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $662.98 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $577.18 | 2021-2025 | |
| Abbott Laboratories | $450.49 | 2021-2025 | Freestyle Libre 3, Mitraclip |
| Pfizer INC. | $396.82 | 2019-2025 | |
| Lilly USA, LLC | $353.38 | 2019-2023 | Mounjaro, Trulicity, Emgality |
| Novartis Pharmaceuticals Corporation | $236.18 | 2019-2022 | |
| Amgen INC. | $214.92 | 2019-2025 | Evenity |
| Astellas Pharma US INC | $205.47 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $191.10 | 2019-2023 | Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $156.80 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.57 | 2019-2022 | |
| Novus Surgical Solutions LLC | $102.61 | 2022 | |
| Dexcom, INC. | $96.40 | 2020-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.79 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $85.83 | 2019-2022 |
Show all 44 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.